Pharmaceuticals Invest Information

Earnings
Pharma Stock Roundup: Key Earnings Reports from Major Drugmakers Nov 2, 2024
Pharmaceuticals
SciSparc Granted FDA Approval for Phase IIb Trial of Novel Tourette Syndrome Therapy Oct 1, 2024
Pharmaceuticals
Zydus Achieves USFDA Approval for Enzalutamide Capsules, Signalling Potential Market Movement Sep 29, 2024
Pharmaceuticals
FDA Removes Clinical Hold on BMF-219 Trials for Diabetes by Biomea Fusion Sep 27, 2024
Pharmaceuticals
AstraZeneca Pharma Gains CDSCO Approval for Durvalumab Importation Sep 25, 2024
Pharmaceuticals
Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU Sep 21, 2024
Pharmaceuticals
argenx Highlights the Lancet Neurology Publication of Groundbreaking ADHERE Study Data for CIDP Treatment Sep 20, 2024
Pharmaceuticals
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications Sep 18, 2024
Pharmaceuticals
Novartis's Kisqali Demonstrates a 28.5% Decrease in Recurrence Risk in Early Breast Cancer Patients Sep 17, 2024
Pharmaceuticals
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents Sep 14, 2024
Pharmaceuticals
Emergent BioSolutions Secures $41.9 Million BARDA Option for Ebanga™ Ebola Treatment Development Sep 13, 2024
Pharmaceuticals
Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition Aug 30, 2024
Pharmaceuticals
Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients Aug 28, 2024
Pharmaceuticals
Regeneron Showcases Respiratory Treatments at ERS 2024 Congress Aug 26, 2024
Companies
Hims & Hers Health Soars Amid Demand for GLP-1 Weight Loss Alternatives Aug 20, 2024
Finance
Certara Debuts Phoenix™ Version 8.5 Software to Advance Drug Development Aug 16, 2024
Pharmaceuticals
Aarti Drugs' Baddi Unit Receives EIR from USFDA, Positive Signal for Investors Jul 30, 2024
Finance
An Insight into Investment Trends: Trading Costs, Pharmaceuticals, and Alphabet Inc. Jul 29, 2024
Companies
Addex Therapeutics Faces Setback as Partner Halts ADX71149 Development in Epilepsy Jul 22, 2024
Stocks
Investment Alert: Marinus Pharmaceuticals Investors Encouraged to Review Losses Jul 14, 2024
Pharmaceuticals
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients Jul 10, 2024
Pharmaceuticals
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment Jul 4, 2024
Stocks
Dr Reddy's Laboratories Share Price Rallies Following Nicotinell Acquisition Despite Brokerage Skepticism Jun 27, 2024
Pharmaceuticals
WHO and Eli Lilly Warn Against Counterfeit Weight-Loss Medications Jun 21, 2024
Companies
Glenmark Clinches USFDA Approval for Esomeprazole Magnesium Delayed-Release Capsules Jun 13, 2024
Markets
Market Watch: Inflation Worries Trigger Stock Decline; Apple's AI Prospects Attract Investors Jun 12, 2024
Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Pharmaceuticals
Novartis Phase III Trial Shows Atrasentan Promising for IgA Nephropathy Treatment May 26, 2024
Pharmaceuticals
Sobi's Emapalumab-lzsg Granted FDA Fast Track Designation for Macrophage Activation Syndrome May 25, 2024
Pharmaceuticals
Sobi to Unveil Myelofibrosis Treatment Data at ASCO 2024 May 25, 2024
Pharmaceuticals
The Rising Trend of Weight-Loss Medications Among Youths: The Tale of Wegovy and its Impact May 23, 2024
Finance
Inhibikase Therapeutics Sets Terms for Registered Direct Offering to Raise $4.0 Million May 21, 2024
Pharmaceuticals
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP May 14, 2024
Companies
Recursion Pharmaceuticals Soars on Q1 Earnings Beat May 10, 2024
Pharmaceuticals
NewAmsterdam Pharma Announces Upcoming R&D Day Featuring Key Opinion Leaders on May 16, 2024 May 2, 2024
Stocks
Amylyx Pharmaceuticals (AMLX) Shares Plunge Following Phase 3 Setback and Legal Troubles Mar 13, 2024
Pharmaceuticals
Arcutis Announces Key Roflumilast Cream Data for Young Children with Atopic Dermatitis Mar 11, 2024
Stocks
Quoin Pharmaceuticals Gains FDA Approval to Include Teens in Netherton Syndrome Studies, Boosting QNRX Shares Mar 5, 2024
Pharmaceuticals
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment Mar 5, 2024
Pharmaceuticals
SciSparc Advances Autism Spectrum Disorder Treatment with SCI-210 Clinical Trial Progression Mar 1, 2024
Pharmaceuticals
Global Topical Antibiotics Market Set to Expand to USD 10.0 Billion by 2031, Progressing at 5.1% CAGR Feb 21, 2024
Pharmaceuticals
FDA Approves Asthma Drug Xolair for Treating Severe Food Allergies Feb 17, 2024
Legal
Class Action Suit Filed Against Amylyx Pharmaceuticals -- Investors Prompted to Seek Legal Counsel Feb 11, 2024
Companies
Pharmaceutical Giants Defend Drug Pricing in Senate Hearing Amid Sanders' Critique Feb 10, 2024
Pharmaceuticals
Agios Pharmaceuticals AGIO Braces for Potential Decline in Q4 Earnings Feb 9, 2024
Companies
Inhibikase Therapeutics Provides Update on FDA Pre-NDA Meeting for Cancer Treatment Feb 8, 2024
Pharmaceuticals
EMA Validates Marketing Application for Tisotumab Vedotin, A Potential Treatment for Recurrent or Metastatic Cervical Cancer Feb 3, 2024
Companies
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial Jan 8, 2024
Pharmaceuticals
XORTX Advances Kidney Disease Treatment with a Novel Patent Submission Jan 3, 2024
Companies
Eli Lilly Triumphs in Acquisition of POINT Biopharma, Enhancing Radiopharmaceutical Development Dec 28, 2023
Markets
ReShape Lifesciences Soars on FDA Approval, Premarket Stock Movements Observed Across Various Sectors Dec 14, 2023
Stocks
Four High-Liquidity Stocks for Potentially Robust Returns: PBYI, GCT, AMPH, and DBX Dec 11, 2023
Pharmaceuticals
LITFULO™ Wins Health Canada Nod as Novel Alopecia Areata Treatment Dec 5, 2023
Companies
The Rise of Obesity-Fighting Drugs and Their Impact on Novo Nordisk Dec 4, 2023
Pharmaceuticals
AstraZeneca AZN Cancels Two Key Phase III Trials for Hyperkalemia Drug Lokelma Dec 2, 2023
Stocks
Ramaswamy's Election Pledge to Lift Federal Bans on Cannabis and Psychedelics Sparks Interest in Pharma Sector Nov 25, 2023
Pharmaceuticals
SciSparc Ltd. (NASDAQ:SPRC) Soars on Positive Clinical Trial Launch Nov 25, 2023
Pharmaceuticals
Simcere Pharmaceuticals and Connect Biopharma Announce Collaboration on Innovative Autoimmune Drug Nov 24, 2023
Companies
Nvidia Joins Forces with Alphabet Spinoff SandboxAQ on Drug Discovery and Material Innovation Nov 21, 2023
Earnings
Inhibikase Therapeutics Announces Q3 Financial Results and Activities Update Nov 15, 2023
Stocks
Actinium Pharmaceuticals Receives Sell Rating Upgrade Amid Market Movements Nov 12, 2023
Pharmaceuticals
Wegovy Obesity Drug Shows 20% Reduction in Heart Problem Risk, Could Revolutionize Treatment Nov 12, 2023
Pharmaceuticals
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva Nov 10, 2023
Catalyst Pharmaceuticals Delivers Mixed Q3 Results While Raising 2023 Outlook Nov 9, 2023